1. Badr M, Hassan T, Sakr H, Karam N, Rahman DA, Shahbah D, et al. Chemotherapy induced neutropenia among pediatric cancer patients in Egypt: Risks and consequences. Mol Clin Oncol 2016;5(3):300-6. [
DOI:10.3892/mco.2016.957] [
PMID] [
PMCID]
2. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol 1996;14(3):919-24. [
DOI:10.1200/JCO.1996.14.3.919] [
PMID]
3. Klaassen RJ, Goodman TR, Pham BA, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000;18(5):1012. [
DOI:10.1200/JCO.2000.18.5.1012] [
PMID]
4. Hakim H, Flynn PM, Srivastava DK, Knapp KM, Li C, Okuma J, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 2010;29(1):53-9. [
DOI:10.1097/INF.0b013e3181c3f6f0] [
PMID]
5. Adamson PC. Improving the outcome for children with cancer: development of targeted new agents. CA Cancer J Clin 2015;65(3):212-20. [
DOI:10.3322/caac.21273] [
PMID] [
PMCID]
6. Talcott JA. Assessing risk in cancer patients with fever and neutropenia. In: Febrile Neutropenia. Springer; 1997.p.23-7. [
DOI:10.1007/978-3-642-60443-0_5]
7. Aquino VM, Tkaczewski I, Buchanan GR. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis 1997;25(1):74-8. [
DOI:10.1086/514512] [
PMID]
8. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer Interdiscip Int J Am Cancer Soc 1999;86(1):126-34.
https://doi.org/10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1 [
DOI:10.1002/(SICI)1097-0142(19990701)86:13.0.CO;2-1]
9. Chaudhary N, Kosaraju K, Bhat K, Bairy I, Borker A. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study. J Pediatr Hematol Oncol 2012;34(8):617-23. [
DOI:10.1097/MPH.0b013e3182677fc6] [
PMID]
10. Šegulja S, Ružić A, Dujmić D, Baždarić K, Roganović J. Simple predictors of the re-occurrence of severe febrile neutropenia episode: a single-center retrospective cohort study in pediatric patients with malignant diseases. Croat Med J 2019;60(1):20. [
DOI:10.3325/cmj.2019.60.20] [
PMID] [
PMCID]
11. Ortega, M., Rovira, M., Almela, M. et al. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004;33:741-4. [
DOI:10.1038/sj.bmt.1704409] [
PMID]
12. Gurlinka S, Kini P, Aroor S, Mundkur S. Factors Associated with Adverse Outcome in Pediatric Febrile Neutropenia: Results from a Tertiary Care Hospital. Int J Pediatr 2017;5(12):6447-55. [
URL]
13. Moon JM, Chun BJ. Predicting the complicated neutropenic fever in the emergency department. Emerg Med J 2009;26(11):802-6. [
DOI:10.1136/emj.2008.064865] [
PMID] [
PMCID]